F-star Therapeutics, Inc.

About F-star Therapeutics, Inc.

F-star is a leading clinical-stage biopharmaceutical company delivering tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. By developing medicines that seek to block tumor immune evasion, the Company’s goal is to offer patients with cancer greater and more durable benefits than current immuno-oncology treatments. Through its proprietary tetravalent, bispecific antibody (mAb²™) format, F-star is generating best-in-class drug candidates with broad therapeutic index and monoclonal antibody-like manufacturability. Building on the combined expertise of its world-class management team and scientific leadership, F-star is poised to deliver the next breakthrough immunotherapies for patients with cancer.

Write Your Reviews

Writing great reviews may help others discover the places that are just apt for them. Here are a few tips to write a good review:

3 Star

Be the First One To Review This Listing!!!

Company Info

Year Founded
Number of Employees 100 - 249
Minimal Budget $25,000 - $50,000

Our Location

35 Parkwood Dr, Hopkinton , Massachusetts 01748 , United States
View Map